Characterizing Normal Appearing and Diseased White Matter in Multiple Sclerosis Using Quantitative MRI

Combining SIENA and SIENAx for Improved Quantification of Grey and White Matter Atrophy

Decreased Creatine in NAWM Suggest a Reduced Gliosis in Natalizumab Treated MS Patients

Histogram Analysis of Fractional Anisotropy and Mean Diffusivity: Distinguishing Tumefactive Demyelinating Lesions from High-Grade Glioma Using DTI

Histological Basis of Diffusely Abnormal White Matter in Multiple Sclerosis: Evidence for a Primary Lipid Abnormality